YTHDF2 and prostate carcinoma: Another study had the similar results, YTHDF2 mediated the degradation of tumor suppressors LHPP and NKX3–1 mRNA and indirectly induced AKT phosphorylation to promote prostate cancer progression in an m6A-dependent manner (75).